Zusammenfassung
Das Thema der Immundiagnostik beim Harnblasenkarzinom konzentriert sich auf die Beantwortung der Fragen: Spielen immunologische Phänomene beim Harnblasenkarzinom eine Rolle, welche kennen wir und was ist bisher über deren klinische Bedeutung bekannt?
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Adolphs H-D, Steffen L (1977) Evaluation of the immunocompetence of patients with transito-rial cell carcinoma of the bladder. Urol Res 5: 29–33
Bean M (1977) Some immunological considerations relevant to the study of human bladder cancer. Cancer Res 37: 2879–2884
Brosman S, Elhilali M, Vescera C, Fahey J (1979) Immune response in bladder cancer patients. J Urol 121: 162–169
Catalona WJ, Smolev JK, Harty JI (1975) Prognostic value of host immunocompetence in urologic cancer patients. J Urol 114: 922
Catalona WJ, Oldham RK, Herberman RB, Djeu JY, Cannon GB (1977) Lack of specifity of lymphocyte-mediated cytotoxicity against the bladder cancer cell line, T24. J Urol 118: 254–257
Clausen JE (1971) Tuberculin-induced migration inhibition of human peripheral leucocytes in agarose medium. Acta Allergol (Kbh) 26: 56–80
Cunningham AJ (1976) Self-tolerance maintained by active suppressor mechanisms. Transplant Rev 31: 23–49
Decenzo JM, Howard P, Irish CE (1975) Antigenic detection and prognosis of patients with stage A transitional cell bladder carcinoma. J Urol 114: 874–878
Eickenberg H-U, Thiel U, Ringen R-H (1978) Immunologie und Röntgendiagnostik. Verh. Ber. der Dtsch. Ges. für Urologie, 29. Tagung. Springer, Berlin Heidelberg New York, S 57–61
Flamm J, Burkert S (1982) Zur Korrelation des Immunprofils mit der lokalen Immunozyteninfiltration bei Harnblasentumoren. Urol Int 37: 61–67
Flamm J, Sagaster P, Micksche M (1978) Klinische und immunologische Untersuchungen bei Patienten mit Harnblasentumoren. Urologe [A] 17: 111–116
Herr H (1979) Suppressor cells in the pelvic lymph nodes regional to bladder cancer. J Surg Oncol 11: 289–293
Klippel KF, Walz HP, Kreutz J, Moltke T (1978) DNCB-Test und Immunkompetenz. Munch Med Wochenschr 31: 120
Köhler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specifity. Nature 256: 495
Kumar S, Taylor G, Wilsor P, Hurst W (1980) Prognostic importance of specific immunoreactivity in occupational bladder cancer. Br Med J 1: 512–513
Merrin C, Han T (1974) Immune response in bladder cancer. J Urol 111: 170–172
Muhamel E, Shohat B, Servadio C (1982) Immunological profile of patients with transitional cell carcinoma of the bladder. Br J Urol 54: 11–15
Olsson L, Kaplan HS (1980) Human-human hybridomas producing monoclonal antibodies of predefined antigenic specifity. Proc Natl Acad Sci 77: 5439
Olsson CA, Rao CN, Menzoian JE, Byrd WE (1972) Immunologic unreactivity in bladder cancer patients. J Urol 107: 607–609
O’Toole C, Perlmann P, Unsgaard B, Moberger G, Edsmyr F (1972) Cellular immunity to human urinary bladder carcinoma. I. Correlation to clinical stage and radiotherapy. Int J Cancer 10: 77–91
Zacharski LR, Linman JW (1971) Lymphocytopenia: its causes and significance. Mayo Clin Proc 46: 168
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bauer, H.W. (1984). Immundiagnostik beim Harnblasenkarzinom. In: Bichler, KH., Harzmann, R. (eds) Das Harnblasenkarzinom. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69535-3_17
Download citation
DOI: https://doi.org/10.1007/978-3-642-69535-3_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-69536-0
Online ISBN: 978-3-642-69535-3
eBook Packages: Springer Book Archive